Back to Results

Agfa Gevaert NV ADR (AFGVY)

Agfa-Gevaert NV ADR is a depositary receipt representing common stock of Agfa-Gevaert NV and trades on OTC Markets. The underlying company develops, manufactures, and markets analog and digital systems for customers worldwide. Its activities are organized into four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS).

The HealthCare IT segment focuses on enterprise imaging platforms for healthcare providers. Digital Print & Chemicals supplies printers, inks, software, and related materials for sign and display, packaging, industrial inkjet, and other specialty applications, including printable synthetic papers and films. Radiology Solutions serves diagnostic imaging markets with analog and digital imaging technology, X-ray film, hardcopy film, printers, digital radiography equipment, image processing software, and SmartXR workflow assistance tools. CONOPS provides film and chemicals as well as support services.

Agfa-Gevaert was founded in 1867 and is headquartered in Mortsel, Belgium.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-AFGV.Y
$2.46
7.3% Upside
Fair
Not available
Not available
Fair
0.0%
November 10, 2026
0.3x
0.1x
67.448 M
212.2 M
76.5%
100.0%
8.7
-7.4%
Valuation • Fair Value

Agfa Gevaert NV ADR (OTC-AFGV.Y) Fair Value by Valuation Model

Review the available estimates for Agfa Gevaert NV ADR (OTC-AFGV.Y), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$2.46

Estimated upside of 7.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$3.78

Discounted cash flow valuation reference.

Comps Fair Value

$2.24

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Agfa Gevaert NV ADR (OTC-AFGV.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Agfa Gevaert NV ADR (OTC-AFGV.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.228 B

Current operating scale indicator.

Revenue Forecast

1.232 B

Forward revenue estimate.

EBITDA

20.555 M

Current operating profitability reference.

EBITDA Forecast

78.605 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Agfa Gevaert NV ADR (OTC-AFGV.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Agfa Gevaert NV ADR (OTC-AFGV.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.14

No elevated caution signal from this screen.

Altman Z-Score

8.7

Relatively strong balance-sheet zone.

FCF / Net Income

-7.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Agfa Gevaert NV ADR (OTC-AFGV.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Agfa Gevaert NV ADR (OTC-AFGV.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Agfa Gevaert NV ADR (OTC-AFGV.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Agfa Gevaert NV ADR (OTC-AFGV.Y) Stock FAQ

Data-supported answers about Agfa Gevaert NV ADR (OTC-AFGV.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$2.46
Estimated upside 7.3%
Valuation Rating
Undervalued
Estimated upside of 7.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Agfa Gevaert NV ADR (OTC-AFGV.Y) is $2.46. This implies an estimated upside of 7.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 7.3% versus the current market price.

The current financial health read for Agfa Gevaert NV ADR (OTC-AFGV.Y) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Agfa Gevaert NV ADR (OTC-AFGV.Y) is November 10, 2026.

The latest available data indicates no current dividend yield for Agfa Gevaert NV ADR (OTC-AFGV.Y).

The current market capitalization listed for Agfa Gevaert NV ADR is 67.448 M.

The current enterprise value listed for Agfa Gevaert NV ADR is 212.2 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Agfa Gevaert NV ADR is OTC-AFGV.Y, and the stock is listed on OTC Markets.

Agfa Gevaert NV ADR (OTC-AFGV.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Agfa Gevaert NV ADR is 76.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Agfa Gevaert NV ADR is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

VEEV NYSE Veeva Systems Inc Class A Fair Value Fair Market Cap 42.244 B
WAY NASDAQ Waystar Holding Corp Fair Value Undervalued Market Cap 4.915 B
DOCS NYSE Doximity Inc Fair Value Undervalued Market Cap 4.725 B
HTFL NASDAQ Heartflow Inc Fair Value Overvalued Market Cap 4.362 B
SDGR NASDAQ Schrodinger Inc Fair Value Overvalued Market Cap 2.297 B
CERT NASDAQ Certara Inc Fair Value Undervalued Market Cap 1.347 B
GDRX NASDAQ Goodrx Holdings Inc Fair Value Undervalued Market Cap 1.174 B
TDOC NYSE Teladoc Inc Fair Value Undervalued Market Cap 1.154 B
HSTM NASDAQ HealthStream Inc Fair Value Fair Market Cap 887.6 M
SOPH NASDAQ Sophia Genetics SA Fair Value Overvalued Market Cap 687 M
PHR NYSE Phreesia Inc Fair Value Undervalued Market Cap 626.9 M
CTEV NYSE Claritev Corp Fair Value Overvalued Market Cap 499.1 M
EVH NYSE Evolent Health Inc Fair Value Fair Market Cap 429.6 M
SLP NASDAQ Simulations Plus Inc Fair Value Undervalued Market Cap 372.3 M
AMWL NYSE American Well Corp Fair Value Undervalued Market Cap 224.7 M
LFMD NASDAQ LifeMD Inc Fair Value Undervalued Market Cap 159.1 M
OPRX NASDAQ OPTIMIZERx Corp Fair Value Bargain Market Cap 143.5 M
HCAT NASDAQ Health Catalyst Inc Fair Value Fair Market Cap 142.2 M
DH NASDAQ Definitive Healthcare Corp Fair Value Bargain Market Cap 129.3 M
CCLD NASDAQ CareCloud Inc Fair Value Fair Market Cap 91.362 M